December 15, 2023
Investors suing Boston Scientific Inc. for touting a heart valve product that was later pulled from the market announced Friday that they have settled their stock suit against the medical device maker for $38.5 million.
October 23, 2023
Boston Scientific Corp.'s directors and top executives knew that a heart valve device that the company launched in 2019 was frequently causing complications and injuries, but nevertheless touted the product for months before pulling the device from the market, a new shareholder's Delaware Chancery Court complaint says.
July 27, 2023
Boston Scientific Corp. asked a Massachusetts federal judge Thursday to disqualify a German asset-management firm from serving as lead plaintiff in a proposed shareholder class action, arguing that the firm continued buying stock in Boston Scientific even after learning a highly touted heart device was pulled from the market.
April 24, 2023
Investors claiming Boston Scientific Inc. misled them about the prospects of a medical device asked a Massachusetts federal judge who had trimmed a previous version of their complaint to certify their class in a suit in which they claim thousands of investors were harmed when the device was ultimately recalled and the company's stock price fell.
December 21, 2022
A Massachusetts federal judge trimmed a proposed class action Tuesday against medical device maker Boston Scientific and its executives, saying most of the misrepresentations alleged in the complaint are non-actionable and that the plaintiffs have not sufficiently alleged all the executives intentionally misled investors with their statements.
January 04, 2022
The U.S. Securities and Exchange Commission is not bringing securities claims against Boston Scientific for halting the production of its Lotus Edge heart device, the company said Monday as it sought to undercut a related suit brought by investors in New York and Massachusetts.
November 19, 2021
Investors claiming Boston Scientific Inc. misled them about the prospects of a medical device were told by a Boston federal judge on Friday to present him the "jugular" of their case and not waste precious time on rhetorical and argumentative "capillaries."